Personalized Care to Prevent Functional Decline in Older Adults with Diabetes A Randomized Study Using Comprehensive Geriatric Assessment

What this Trial Is About

Researchers are investigating whether a personalized care plan based on Comprehensive Geriatric Assessment CGA can reduce functional decline in older adults aged 75 and above with diabetes. Diabetes in older adults often leads to greater risks of disability, functional loss, and earlier mortality, with a need for treatment approaches that address functional outcomes important to patients. This randomized controlled trial compares the CGA-based care to usual diabetes care to better understand its impact on physical performance and other patient-centered outcomes. The study involves two groups one receiving usual diabetes care from a diabetologist, and the other receiving an additional CGA by a geriatrician. This assessment helps create a personalized diagnostic and therapeutic plan addressing the patients functional status and preferences. The intervention group receives this tailored plan alongside usual care, while the control group continues with usual care alone. Follow-up visits are scheduled at 6 and 12 months to monitor progress. Participants will undergo evaluations including physical performance tests using the Short Physical Performance Battery SPPB, cognitive function tests, and assessments for sarcopenia, disability, and hospitalization rates. Data on glycated hemoglobin levels and time spent at home will also be collected. Assessments occur at baseline, 6 months, and 12 months. The study aims to provide evidence on the benefits of CGA-driven care in maintaining function and quality of life among older adults with diabetes, with total participation lasting at least 12 months.

Comprehensive Approach to Reduce Elderly Functional Decline in Diabetes: the CARED Study